Vantictumab

(Synonyms: OMP-18R5)
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab can be studied against cancers through direct actions on tumor cells, including CSCs, and effects on the stroma, such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.00%
  • CAS. Nr.: 1345009-45-1
  • Molecular Weight:143.16 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Vantictumab

More

Alle Wnt Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00